Clinical Trial: Randomized, Open Label Study to Examine the Outcomes of Physiologic Insulin Resensitization in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187479) titled 'Randomized, Open Label Study to Examine the Outcomes of Physiologic Insulin Resensitization in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus' on Sept. 18.

Brief Summary: The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease (Stages 4 and 5) Kidney Disease Type 2 Diabetes

Intervention: OTHER: Physiologic Insulin Resensitization (PIR)

PIR is a physician-directed treatment that uses an exterio...